The effect of restraint stress on glucocorticoid receptors in mouse spleen lymphocytes: Involvement of the sympathetic nervous system

NeuroImmunoModulation

Volumn 17, Issue 5, 2010, Pages 298-304

  Warner, Arielle ^a   Ovadia, Haim ^a   Tarcic, Nora ^b   Weidenfeld, Joseph ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Chlorisondamine; Glucocorticoid receptor; Neuroimmunomodulation; Restraint stress; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR; CHLORISONDAMINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC INNERVATION; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BLOCKING; SPLEEN LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED BALB C; NEUROIMMUNOMODULATION; RECEPTORS, GLUCOCORTICOID; RESTRAINT, PHYSICAL; SPLEEN; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 77950930983     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000292019     Document Type: Article

References (43)

1. Ader R, Cohen N, Felten D: Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995; 345: 99-103.
2. Chrousos GP: The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362.
3. Ovadia H, Saphier D, Weidenfeld J, Abramsky O: Neuroimmunomodulation: the interaction between the nervous system and the immune system. Isr J Med Sci 1989; 25: 7-14.
4. Felten SY, Felten DL, Bellinger DL, et al: Noradrenergic sympathetic innervation of lymphoid organs. Prog Allergy 1988; 43: 14-36.
5. Loza MJ, Foster S, Peters SP, Penn RB: Betaagonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 2006; 107: 2052-2060.
6. Watanabe Y, Lai RT, Higuchi H, Maeda H, Yoshida H: Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-) 3 H-dihydroalprenolol binding sites by cytoplasmic fractions. Life Sci 1981; 28: 1399-1405.
7. Kurz B, Feindt J, von Gaudecker B, Kranz A, Loppnow H, Mentlein R: Beta-adrenoceptor- mediated effects in rat cultured thymic epithelial cells. Br J Pharmacol 1997; 120: 1401-1408.
8. Glac W, Borman A, Badtke P, Stojek W, Orlikowska A, Tokarski J: Amphetamine enhances natural killer cytotoxic activity via beta-adrenergic mechanism. J Physiol Pharmacol 2006; 57(suppl 11):125-132.
9. Loza MJ, Peters SP, Foster S, Khan IU, Penn RB: Beta-agonist enhances type 2 T-cell survival and accumulation. J Allergy Clin Immunol 2007; 119: 235-244.
10. Madden KS, Ackerman KD, Livnat S, Felten SY, Felten DL: Neonatal sympathetic denervation alters development of natural killer (NK) cell activity in F344 rats. Brain Behav Immun 1993; 7: 344-351.
11. Madden KS, Stevens SY, Felten DL, Bellinger DL: Alterations in T lymphocyte activity following chemical sympathectomy in young and old Fischer 344 rats. J Neuroimmunol 2000; 103: 131-145.
12. Rice PA, Boehm GW, Moynihan JA, Bellinger DL, Stevens SY: Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J Neuroimmunol 2001; 114: 19-27.
13. del Rey A, Roggero E, Kabiersch A, Schafer M, Besedovsky HO: The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice. J Immunol 2006; 176: 7079-7086.
14. Pal E, Tabira T: Autonomic regulation of experimental autoimmune encephalomyelitis: the role of interferon-gamma. Neuroimmunomodulation 2002; 10: 80-84.
15. Savino W, Silva PO, Besedovsky H: Network of bidirectional interactions between the neuroendocrine and immune systems. Preface. Ann NY Acad Sci 2009; 1153:xi.
16. Tarcic N, Levitan G, Ben-Yosef D, Prous D, Ovadia H, Weiss DW: Restraint stress-induced changes in lymphocyte subsets and the expression of adhesion molecules. Neuroimmunomodulation 1995; 2: 249-257.
17. Tarcic N, Ovadia H, Weiss DW, Weidenfeld J: Restraint stress-induced thymic involution and cell apoptosis are dependent on endogenous glucocorticoids. J Neuroimmunol 1998; 82: 40-46.
18. Farias-Silva E, dos Santos IN, Corezola do Amaral ME, Grassi-Kassisse DM, Spadari- Bratfisch RC: Glucocorticoid receptor and beta-adrenoceptor expression in epididymal adipose tissue from stressed rats. Ann NY Acad Sci 2004; 1018: 328-332.
19. Ovadia H, Sobcho A, Wholmann A, Weidenfeld J: Cellular nuclear binding and retention of glucocorticoids in rat lymphoid cells: effect of long-term adrenalectomy. Neuroimmunomodulation 1995; 2: 339-346.
20. Schmidt P, Holsboer F, Spengler D: Beta(2)- adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. Mol Endocrinol 2001; 15: 553-564.
21. Tritos N, Kitraki E, Philippidis H, Stylianopoulou F: Neurotransmitter modulation of glucocorticoid receptor mRNA levels in the rat hippocampus. Neuroendocrinology 1999; 69: 324-330.
22. Weidenfeld J, Feldman S: Effect of 6-hydroxydopamine and 5,7-dihydroxytryptamine on tissue uptake and cell nuclear retention of corticosterone in the rat hypothalamus. Brain Res 1991; 566: 140-145.
23. Yau JL, Seckl JR: Central 6-hydroxydopamine lesions decrease mineralocorticoid, but not glucocorticoid receptor gene expression in the rat hippocampus. Neurosci Lett 1992; 142: 159-162.
24. Angelucci L, Patacchioli FR, Scaccianoce S, Martucci E, Capasso M: Hippocampal glucocorticoid binding: serotoninergic regulation and drug effects; relevance to behavioral- endocrine activities and depression. Ann Ist Super Sanita 1982; 18: 35-39.
25. Bener D, Wohlman A, Itzik A, Yirmiya R, Ben-Hur T, Weidenfeld J: Glucocorticoid resistance following herpes simplex-1 infection: role of hippocampal glucocorticoid receptors. Neuroendocrinology 2007; 85: 207-215.
26. Nakamura S: Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex. Neurosci Lett 1990; 111: 64-68.
27. O'Donnell D, Francis D, Weaver S, Meaney MJ: Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue: a comparison between Western blotting and receptor binding assays. Brain Res 1995; 687: 133-142.
28. Besedovsky HO, del Rey A: Introduction: immune-neuroendocrine network. Front Horm Res 2002; 29: 1-14.
29. de Kloet ER, Reul JM, de Ronde FS, Bloemers M, Ratka A: Function and plasticity of brain corticosteroid receptor systems: action of neuropeptides. J Steroid Biochem 1986; 25: 723-731.
30. Reul JM, de Kloet ER: Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem 1986; 24: 269-272.
31. D'Elia M, Patenaude J, Bernier J: Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice. Am J Physiol Endocrinol Metab 2009; 296: 97-104.
32. Spencer RL, Miller AH, Moday H, Stein M, McEwen BS: Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology 1993; 133: 1941-1950.
33. Padgett DA, Glaser R: How stress influences the immune response. Trends Immunol 2003; 24: 444-448.
34. Weiss JM, Quan N, Sundar SK: Widespread activation and consequences of interleukin-1 in the brain. Ann NY Acad Sci 1994; 741: 338-357.
35. Dong Y, Aronsson M, Gustafsson JA, Okret S: The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 1989; 264: 13679-13683.
36. Webster JC, Oakley RH, Jewell CM, Cidlowski JA: Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98: 6865-6870.
37. Koff WC, Fann AV, Dunegan MA, Lachman LB: Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res 1986; 5: 239-247.
38. Vizi ES, Elenkov IJ: Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 2002; 53: 229-244.
39. Rosas-Ballina M, Ochani M, Parrish WR, et al: Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105: 11008-11013.
40. van Maanen MA, Lebre MC, van der Poll T, et al: Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009; 60: 114-122.
41. Wang H, Yu M, Ochani M, et al: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
42. Zilberman Y, Zafrir E, Ovadia H, Yefenof E, Guy R, Sionov RV: The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4+8+ thymic lymphoma cells. Cell Immunol 2004; 227: 12-23.
43. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5: 25-44.